GYPA and acute myeloid leukemia: In one case of peripheral blood from an AML patient, CD45+/CD19+/CD235a+ TER cells clearly existed, although only a small proportion of such TER cells were strongly CD19-positive, and the remaining cells were weakly CD19-positive (Figure 4C).